NCT
INICIO RECIENTES ARCHIVO COVID-19
INICIO RECIENTES ARCHIVO PUBLICAR INSTRUCCIONES
PARA AUTORES COVID-19 ENTRAR / REGISTRARSE HISTORIA NOSOTROS DIRECTORIO CONTACTO
Intervenciones que ameritan discusiones personales y familiares

Bulectomía
Cirugía de reducción de volumen
Trasplante pulmonar
Otras alternativas en procedimientos invasivos
Consideraciones en otro tipo de cirugías en EPOC





2007, Suplemento 2

2007; 66 (S2)






RESUMEN

En el paciente con EPOC que tiene limitaciones físicas importantes en relación con su enfermedad, la propuesta de un tratamiento quirúrgico (Bulectomía, reducción de volumen pulmonar o trasplante) puede ser una gran esperanza. De ahí, que debe evaluarse la factibilidad de estos procedimientos antes de sugerirlos. Estos procedimientos significan también riesgos importantes para el paciente, al punto que podría significar la diferencia entre tener una mejor calidad de vida o morir en el intento. Por ello este tipo de intervenciones deben analizarse con el paciente y discutirse también con los familiares para determinar y evaluar los riesgos y beneficios.

PALABRAS CLAVE

.

REFERENCIAS

  1. Patients at high risk of death after lung volumen reduction surgery. National Emphysema treatment trial research group. N Engl J Med 2002; 345: 1075-1083.

  2. Rationale and design of the national emphysema treatment trial. A prospective randomized trial of lung volumen reduction surgery. The NETT research group. J cardiopulmonary Rehabil 2000; 20: 24-36.

  3. Hsenpud JD, Norvick RJ, Benneth LE, Reck BM, Fiol B et al. The registry of the international society for heart and lung transplantation: Thirteenth official report 1996. J Heart Lung Transplant 1996; 15: 655-674.

  4. Machuzak MS, Lipson DA. Surgical Options in chronic obstructive pulmonary disease. Clin Pulm Med 2006; 13: 1-7.

  5. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2006. www.goldcopd.org

  6. Laros CD, Gelissen HJ, Bergstein PG, Van den Bosch JM, Vanderchueren RG, et al. Bullectomy for giant bullae in emphysema. J Thorac Cardiovasc Surg 1986; 91: 63-70.

  7. Wesley JR, MacLeod WM, Mullard KS. Evaluation and surgery of bullous emphysema. J Thorac Cardiovasc Surg 1972; 63: 945-955.

  8. Senbaklavaci O, Wisser W, Klepetko W. Successful lung volume reduction surgery brings patients into better condition for later lung transplantation. Eur J Cardiothorac Surg 2002; 22: 363-367.

  9. Meyers BF, Yusen RD, Patterson GA, Cooper JD. Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation. J Thorac Cardiovac Surg 2001; 122: 10-17.

  10. Cooper JD, Patterson A, Lefrak S. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg 1996; 112: 1319-1330.

  11. Oey LF, Waller DA, Morgan MDL. Lung volume reduction surgery a comparison of the long term outcome of unilateral vs. bilateral approaches. Eur J Cardiothorac Surg 2002; 22: 610-614.

  12. The National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348: 2059–2073.

  13. The National Emphysema Treatment Trial Research Group. Rationale and design of the National Emphysema Treatment Trial: A prospective randomized trial of lung volume reduction surgery. Chest 1999; 116: 1750–1761.

  14. Nathan SD, Edwards LB, Barnett SD, Ahmad S, Burton NA. Outcomes Of COPD lung transplant recipients after lung volume reduction surgery. Chest 2004; 126: 1569-1574.

  15. Nathan SD. Lung transplantation: Disease-specific considerations for referral. Chest 2005; 127: 1006-1016.

  16. Nathan SD. Lung transplant candidate selection and clinical outcomes: Strategies for improvement in priorization. Curr Opin Organ Transplant 10: 216-220.

  17. Martinez FJ, Chang A. Surgical therapy for chronic obstructive pulmonary disease. Semin Resp Crit Care Med 2005; 26: 167-191.

  18. Barr ML, Bourge RC, Orens JB, McCurry KR, Ring WS, et al. Thoracic organ transplantation in the United States 1994-2003. Am J Transplant 2005; 5: 934–949.

  19. Smith CM. Patient selection, evaluation, and preoperative management for lung transplant candidates. Clin Chest Med 1997; 18: 183-196.

  20. Schulman LL. Lung transplantation for chronic obstructive pulmonary disease. Clin Chest Med 2000; 21: 849-866.

  21. Wan IY, Toma TP, Geddes DM, Snell G, Williams T, et al. Bronchoscopic lung volume reduction for end- stage emphysema: report on the first 98 patients. Chest 2006; 129: 519-526.

  22. Smetana GW. Preoperative pulmonary evaluation. N Engl J Med 1999; 340: 937-944.

  23. Trayner E Jr., Celli BR. Postoperative pulmonary complications. Med Clin North Am 2001; 85: 1129-1139.

  24. Weisman IM. Cardiopulmonary exercise testing in the preoperative assessment for lung resection surgery. Semin Thorac Cardiovasc Surg 2001; 13: 116-125.

  25. Bolliger CT, Perruchoud AP. Functional evaluation of the lung resection candidate. Eur Respir J 1998; 11: 198-212.

  26. Schuummans MM, Diacon AH, Bolliger CT. Functional evaluation before lung resection candidate. Clin Chest Med 2002; 23: 159-172.

  27. Celli BR. MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.


2007, Suplemento 2

2007; 66 (S2)